Anavex Life Sciences Corp. Investors Seeking Lead Plaintiff Role Have Until November 30th to Contact Bragar Eagel & Squire, P.C.

A class action lawsuit has been filed against Anavex Life Sciences Corp. for alleged securities violations between November 26, 2025 and August 28, 2026. The complaint alleges the company and its executives made false statements regarding adequate internal controls, understated regulatory challenges related to former CEO Christopher Missling's misconduct, and misrepresented business operations and prospects. Investors who suffered losses can apply to be lead plaintiff by November 30, 2026.